Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
Trial details
- Registry ID
- NCT02716246
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSHNCT02716246 | RARE | Phase 2, Phase 3 | Recruiting | 2029-03Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |